USA – Implicity, a Cambridge, MA-based provider of a remote patient monitoring and cardiac data management solutions, raised $23M in Series A funding.
The round was led by Crédit Mutuel Innovation and Bpifrance, with participation from BNP Paribas Development, Serena, XAnge and Karista.The company intends to use the funds to:Led by CEO Dr. Arnaud Rosier, Implicity is a software company that provides a universal cardiac remote monitoring and research platform to clinics and service companies. Its AI-based technology and cardiac data management solutions enable healthcare professionals around the world to have a more holistic approach to caring for cardiac patients. This new funding comes months after the company received FDA clearance for a novel AI algorithm that analyzes ECG episodes from Implantable Loop Recorders (ILRs).IMPLICITY® covers more than 60,000 patients in 100 medical facilities across the United States and Europe.
27/04/2022
